Imagion Biosystems Limited (Company) is committed to ensuring that public confidence is maintained in the Company, its people and the trading of its securities. This policy sets out the company’s trading policy on buying and selling securities of the Company including shares, options, derivatives, managed investment products, superannuation products and any other financial products of the Company that are able to be traded on a financial market (Company’s Securities).
View the Imagion Biosystems Limited Securities Trading Policy.
Imagion Biosystems’ IND Application for MagSense® Phase 2 Clinical Trial Clears FDA Review
Imagion Biosystems, Ltd. (ASX: IBX) has announced that the US Food and Drug Administration (FDA) completed its review of the company’s investigational new drug (IND)
